Drug intelligence / Profile preview

resveratrol + carboxymethyl-beta-glucan

Development stage
Unknown
Lead developer
Noos
Modality
Small Molecules
Administration
Intranasal, Oral
01

Overview

Resveratrol + carboxymethyl-beta-glucan is a combination therapeutic consisting of the natural polyphenol resveratrol and the water-soluble yeast-derived polysaccharide carboxymethyl-beta-glucan. Resveratrol acts as a potent antioxidant and anti-inflammatory agent by modulating pathways such as NF-κB and SIRT1, thereby reducing the production of pro-inflammatory cytokines. Carboxymethyl-beta-glucan serves as an immunomodulator that enhances the activity of innate immune cells, including macrophages and neutrophils, through interaction with pattern recognition receptors like Dectin-1. This combination is primarily utilized in the management of upper respiratory tract diseases, such as allergic rhinitis and recurrent respiratory infections, particularly in children. It is frequently formulated as a nasal spray or oral supplement and is often regulated as a medical device in European markets.

Brand names
ResvisResvis XRResvis Forte
Other names
resveratrol + carboxymethylbetaglucanresveratrol + carboxymethylated beta-glucanresveratrol + carboxymethylated β-glucan
02

Targets

CLEC7A (Dectin-1)

Beyond the preview

Go deeper on resveratrol + carboxymethyl-beta-glucan.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on resveratrol + carboxymethyl-beta-glucan.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call